Chlorotrianisene
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
1,1',1''-(2-chloroethene-1,1,2-triyl)tris(4-methoxybenzene) | |
Clinical data | |
Trade names | Tace |
AHFS/Drugs.com | Multum Consumer Information |
Pregnancy cat. | X (US) |
Legal status | Discontinued |
Routes | Oral |
Pharmacokinetic data | |
Protein binding | 50 to 80% |
Identifiers | |
CAS number | 569-57-3 |
ATC code | G03CA06 |
PubChem | CID 11289 |
DrugBank | DB00269 |
ChemSpider | 10815 |
UNII | 6V5034L121 |
KEGG | D00269 |
ChEBI | CHEBI:3641 |
ChEMBL | CHEMBL1200761 |
Chemical data | |
Formula | C23H21ClO3 |
Mol. mass | 380.864 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Chlorotrianisene (trade name Tace) is a non-steroidal synthetic estrogen that was formerly used for the treatment of menopause, deficiencies in ovary function, and prostate cancer.[1][2]
References
- ↑ Drugs.com: Chlorotrianisene
- ↑ Yuen, B. H.; Pendleton, H. J.; Blair, S. (1977). "Efficacy of bromocriptine and chlorotrianisene in preventing postpartum lactation". Canadian Medical Association journal 117 (8): 919–921. PMC 1880136. PMID 334356.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.